The MarketWatch News Department was not involved in the creation of this content. Cure HHT plays pivotal role in the NIH-sponsored PATH Trial becoming the first successful, large-scale randomized ...
Please provide your email address to receive an email when new articles are posted on . A multicenter research effort yielded findings that may allow for more effective and personalized treatment of ...
People with HHT have a near-typical life expectancy as long as they follow their treatment plan and undergo regular screening for complications. Hereditary hemorrhagic telangiectasia (HHT) is a rare ...
MONKTON, MD, UNITED STATES, March 25, 2026 /EINPresswire.com/ — Cure HHT proudly announces the publication of “Clinical Spectrum of Hereditary Hemorrhagic ...
LAFFAYETTE, NJ – A local family has taken their personal story and turned it into a fundraising event. Sparta High School Athletic Director Steve Stoner’s uncle has a blood disorder known as HHT. They ...
Hereditary hemorrhagic telangiectasia (HHT) is an inherited disorder that affects the blood vessels. A person with HHT may have blood vessels that have not developed properly and may have no ...
New CHORUS data published in Blood show HHT is a serious multisystem bleeding disorder requiring earlier diagnosis, expert care, and research. MONKTON, MD, UNITED ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results